Anti-HCV Agents in Development

Shane Crotty, David Maag, Jamie J. Arnold, Weidong Zhong, Johnson Y. N. Lau, Zhi Hong, Raul Andino, Craig E. Cameron, The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen. Nature Medicine. ,vol. 6, pp. 1375- 1379 ,(2000) , 10.1038/82191

Jacques Banchereau, Ralph M. Steinman, Dendritic cells and the control of immunity Nature. ,vol. 392, pp. 245- 252 ,(1998) , 10.1038/32588

Gunçag Dinçol, Serkan Güvenç, Dedrey Elam, Abdullah Kutlar, Ferdane Kutlar, Hb J- Meerut [alpha 120 (H3) Ala ->Glu (alpha1)] in a Turkish male. International Journal of Medical Sciences. ,vol. 3, pp. 26- 27 ,(2006) , 10.7150/IJMS.3.26

Tetsuro Suzuki, Hideki Aizaki, Kyoko Murakami, Ikuo Shoji, Takaji Wakita, Molecular biology of hepatitis C virus. Journal of Gastroenterology. ,vol. 42, pp. 411- 423 ,(2007) , 10.1007/S00535-007-2030-3

Thierry Poynard, John McHutchison, Michael Manns, Christian Trepo, Karen Lindsay, Zachary Goodman, Mei–Hsiu Ling, Janice Albrecht, PEG-fibrosis project group, Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology. ,vol. 122, pp. 1303- 1313 ,(2002) , 10.1053/GAST.2002.33023

Allan J Zajac, Kaja Murali-Krishna, Joseph N Blattman, Rafi Ahmed, None, Therapeutic vaccination against chronic viral infection: the importance of cooperation between CD4+ and CD8+ T cells Current Opinion in Immunology. ,vol. 10, pp. 444- 449 ,(1998) , 10.1016/S0952-7915(98)80119-2

Alessandra Mangia, Rosanna Santoro, Nicola Minerva, Giovanni L. Ricci, Vito Carretta, Marcello Persico, Francesco Vinelli, Gaetano Scotto, Donato Bacca, Mauro Annese, Mario Romano, Franco Zechini, Fernando Sogari, Fulvio Spirito, Angelo Andriulli, Peginterferon alfa-2b and ribavirin for 12 vs. 24 weeks in HCV genotype 2 or 3. The New England Journal of Medicine. ,vol. 352, pp. 2609- 2617 ,(2005) , 10.1056/NEJMOA042608

Stefan Zeuzem, Maria Buti, Peter Ferenci, Jan Sperl, Yves Horsmans, Janusz Cianciara, Endre Ibranyi, Ola Weiland, Stephanie Noviello, Clifford Brass, Janice Albrecht, Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia Journal of Hepatology. ,vol. 44, pp. 97- 103 ,(2006) , 10.1016/J.JHEP.2005.10.003

E. Lawitz, T. Nguyen, Z. Younes, J. Santoro, N. Gitlin, D. McEniry, R. Chasen, J. Goff, D. Dieterich, S. Knox, K. Kleber, B. Belanger, N.A. Brown, [14] CLEARANCE OF HCVRNA WITH VALOPICITABINE (NM) PLUS PEG-INTERFERON IN TREATMENT-NAIVE PATIENTS WITH HCV-1 INFECTION: RESULTS AT 24 AND 48 WEEKS Journal of Hepatology. ,vol. 46, pp. S9- ,(2007) , 10.1016/S0168-8278(07)61612-2

Takanobu Kato, Tomoko Date, Michiko Miyamoto, Akihiro Furusaka, Katsutoshi Tokushige, Masashi Mizokami, Takaji Wakita, Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon Gastroenterology. ,vol. 125, pp. 1808- 1817 ,(2003) , 10.1053/J.GASTRO.2003.09.023